1. Home
  2. OBT vs CLLS Comparison

OBT vs CLLS Comparison

Compare OBT & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orange County Bancorp Inc.

OBT

Orange County Bancorp Inc.

HOLD

Current Price

$38.34

Market Cap

457.5M

Sector

Finance

ML Signal

HOLD

Logo Cellectis S.A.

CLLS

Cellectis S.A.

HOLD

Current Price

$2.76

Market Cap

394.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OBT
CLLS
Founded
1892
1999
Country
United States
France
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
457.5M
394.4M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
OBT
CLLS
Price
$38.34
$2.76
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$36.00
$8.33
AVG Volume (30 Days)
52.2K
15.2K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
2.12%
N/A
EPS Growth
34.82
N/A
EPS
0.85
N/A
Revenue
N/A
N/A
Revenue This Year
$14.27
N/A
Revenue Next Year
$7.99
$0.98
P/E Ratio
$45.42
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.25
$2.35
52 Week High
$40.10
$5.48

Technical Indicators

Market Signals
Indicator
OBT
CLLS
Relative Strength Index (RSI) 56.89 42.56
Support Level $35.90 $2.65
Resistance Level $38.53 $2.98
Average True Range (ATR) 1.03 0.16
MACD -0.02 0.01
Stochastic Oscillator 74.17 56.25

Price Performance

Historical Comparison
OBT
CLLS

About OBT Orange County Bancorp Inc.

Orange County Bancorp Inc is a community bank holding company providing commercial and consumer banking services to individuals, small businesses, and local governments. It operates through two segments: Banking and Wealth Management. The Banking segment, the primary revenue driver, offers loans such as commercial real estate, construction, commercial & industrial, multifamily, and residential mortgages, along with services like cash management, escrow, deposits, ATMs, and digital banking. The Wealth Management segment provides investment management, trust services (trustee, administrator, custodian), and financial planning and advisory services to individuals and institutions.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Share on Social Networks: